Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and

Antonietta R Silini1, Taja Železnik Ramuta2, Ana Salomé Pires3,4,5

  • 1Centro di Ricerca E. Menni, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.

Insights

Perinatal derivatives (PnDs) show promise for treating cancers and infections. This review details functional assays for reproducible efficacy evaluation of PnDs in preclinical and clinical settings.

Area of Science:

  • Biomedical Science
  • Regenerative Medicine
  • Cell Biology

Background:

  • Perinatal derivatives (PnDs) are tissues, cells, and secretomes from birth-associated sources.
  • PnDs have demonstrated multimodal mechanisms of action in cancer and infection models.
  • Reproducible efficacy evaluation of PnDs remains a critical challenge.

Purpose of the Study:

  • To present commonly used functional assays for assessing PnD antitumor and antimicrobial properties.
  • To discuss the advantages and disadvantages of these assays for PnD functionality assessment.
  • To contribute to the validation of PnDs across various biological functions.

Main Methods:

  • Review of existing literature on functional assays for PnDs.
  • Analysis of assays for evaluating anticancer properties of PnDs.
  • Analysis of assays for evaluating antimicrobial properties of PnDs.

Main Results:

  • Identification of key functional assays for PnD efficacy assessment.
  • Discussion of limitations and strengths of current evaluation methods.
  • Highlighting the need for standardized and reproducible assay protocols.

Conclusions:

  • Standardized functional assays are essential for the reliable validation of PnDs.
  • Further research is needed to optimize assay methodologies for PnD research.
  • This review supports the development of PnDs as therapeutic agents.

Related Concept Videos